Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
The Michael J. Fox Foundation for Parkinson's Research is the world's largest nonprofit funder of Parkinson's research, dedicated to accelerating a cure for Parkinson's disease and improving therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program, and by engaging patients, families, and researchers worldwide.
Serves as the central hub for the Foundation's global research funding operations, strategic planning, patient engagement, advocacy efforts, and administrative functions.
Located in a modern office building in Midtown Manhattan, the headquarters provides a collaborative and accessible space for its team. The focus is on functionality and efficiency to support its critical mission rather than architectural grandeur.
Characterized by a mission-driven, passionate, and collaborative environment. Employees share a strong sense of urgency and dedication to finding a cure for Parkinson's disease, fostering an innovative and fast-paced atmosphere.
The headquarters is the operational core for orchestrating a multi-billion dollar global research portfolio, connecting scientists, patients, donors, and industry partners to accelerate scientific breakthroughs and therapeutic development for Parkinson's disease.
While headquartered in New York City, The Michael J. Fox Foundation for Parkinson's Research operates with a significant global footprint. Its primary global function is the funding and strategic direction of Parkinson's research projects in numerous countries across continents. The Foundation supports international scientific collaborations, funds clinical trials at sites worldwide (e.g., the Parkinson's Progression Markers Initiative - PPMI), engages with global patient advocacy groups, and partners with international biopharmaceutical companies to advance therapeutic development. This global reach ensures that the most promising research, regardless of origin, is supported to accelerate a cure.
111 West 33rd Street, 8th Floor
New York
NY
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, The Michael J. Fox Foundation for Parkinson's Research' leadership includes:
The Michael J. Fox Foundation for Parkinson's Research has been backed by several prominent investors over the years, including:
The Michael J. Fox Foundation saw a key leadership transition in the past year. Holly Teichholtz was appointed Chief Executive Officer in May 2024, succeeding Co-Founder Deborah W. Brooks, who had served as CEO and transitioned to the role of Executive Vice Chair, continuing her significant involvement with the Foundation's mission.
Discover the tools The Michael J. Fox Foundation for Parkinson's Research uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The Michael J. Fox Foundation for Parkinson's Research primarily utilizes contact forms on its official website for inquiries from the public, patients, and researchers. While specific individual staff email address patterns are not broadly publicized for unsolicited contact, a common professional email format for many organizations is [first_initial][last_name]@[domain]. For official correspondence, it is always best to use the designated contact channels on their website.
[first_initial][last_name]@michaeljfox.org
Format
jdoe@michaeljfox.org
Example
70%
Success rate
michaeljfox.org • May 2, 2024
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that its Board of Directors has appointed Holly Teichholtz as Chief Executive Officer. Teichholtz, who has been with the Foundation for over a decade and most recently served as Chief Operating Officer, succeeds Co-Founder Deborah W. Brooks, who has transitioned to the role of Executive Vice Chair....more
michaeljfox.org • April 15, 2024
A landmark development from research heavily supported by The Michael J. Fox Foundation's Parkinson's Progression Markers Initiative (PPMI) has validated an alpha-synuclein seed amplification assay (αSyn-SAA) as a biological test for Parkinson's disease. This biomarker can detect the disease's underlying pathology, even in individuals who have not yet shown clinical symptoms, paving the way for earlier diagnosis and more effective drug development....more
Parkinson's News Today • February 29, 2024
The Michael J. Fox Foundation (MJFF) has awarded more than $6 million to seven research teams to investigate Parkinson's disease associated with mutations in the LRRK2 gene. This funding aims to deepen understanding of LRRK2's role in Parkinson's and accelerate the development of targeted therapies for this genetic form of the disease....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including The Michael J. Fox Foundation for Parkinson's Research, are just a search away.